ETRA

Electra Therapeutics, Inc. - Common stock (ETRA)

About Electra Therapeutics, Inc. - Common stock (ETRA)

Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.

Details

Daily high
$10.46
Daily low
$9.28
Price at open
--
52 Week High
$15.50
52 Week Low
$9.28
Market cap
650.9M
Dividend yield
-
Volume
153
Avg. volume
1.0M
P/E ratio
--

Electra Therapeutics, Inc. - Common stock News

Details

Daily high
$10.46
Daily low
$9.28
Price at open
--
52 Week High
$15.50
52 Week Low
$9.28
Market cap
650.9M
Dividend yield
-
Volume
153
Avg. volume
1.0M
P/E ratio
--